Incivek Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Phase 3 Efficacy and Safety Study of Peginterferon Lambda-1a and Ribavirin With Telaprevir
Condition:   Hepatitis C VirusInterventions:   Biological: Peginterferon Lambda-1a;   Biological: Peginterferon Alfa-2a;   Drug: Ribavirin;   Drug: TelaprevirSponsor:   Bristol-Myers SquibbActive, not recruiting - verified February 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 14, 2012 Category: Research Source Type: clinical trials

Phase 3 Efficacy and Safety Study of Peginterferon Lambda-1a and Ribavirin With Telaprevir
Condition:   Hepatitis C VirusInterventions:   Biological: Peginterferon Lambda-1a;   Biological: Peginterferon Alfa-2a;   Drug: Ribavirin;   Drug: TelaprevirSponsor:   Bristol-Myers SquibbActive, not recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2012 Category: Research Source Type: clinical trials

Phase 3 Efficacy and Safety Study of Peginterferon Lambda-1a and Ribavirin With Telaprevir
Condition:   Hepatitis C VirusInterventions:   Biological: Peginterferon Lambda-1a;   Biological: Peginterferon Alfa-2a;   Drug: Ribavirin;   Drug: TelaprevirSponsor:   Bristol-Myers SquibbActive, not recruiting - verified February 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2012 Category: Research Source Type: clinical trials

Phase 3 Efficacy and Safety Study of Peginterferon Lambda-1a and Ribavirin With Telaprevir
Condition:   Hepatitis C VirusInterventions:   Biological: Peginterferon Lambda-1a;   Biological: Peginterferon Alfa-2a;   Drug: Ribavirin;   Drug: TelaprevirSponsor:   Bristol-Myers SquibbActive, not recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2012 Category: Research Source Type: clinical trials